Clinical Trials Directory

Trials / Completed

CompletedNCT01916642

A Dose-response Study of Lidocaine and Etomidate

Can Intravenous Lidocaine Decrease the Minimal Inducing Dose of Etomidate?: A Randomized Placebo-controlled Dose-response Study.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
100 (actual)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

IV lidocaine administration can reduce the minimal amount of Etomidate and time for induction of anesthesia.

Detailed description

The study was carried out in West China Hospital of Sichuan University, Chengdu, China. All the patients were informed in detail about the procedure and the medications they are going to get. Patients are well informed about the beneficial and possible hazards of the medicines and procedure. Patients are also informed that they can withdraw from the study at any time if they find it uncomfortable or harmful for them. Patients' written informed consent was obtained and registered for the permission from the Hospital's Ethics Board.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine 1mg/kgThe total dosage of Etomidate needed for induction of anesthesia is recorded at last.
DRUGLidocaine 1.5mg/kgsame as other
DRUGLidocaine 2mg/kgsame as other
DRUGLidocaine 2.5mg/kgsame as other

Timeline

Start date
2013-04-01
Primary completion
2013-06-01
Completion
2013-07-01
First posted
2013-08-05
Last updated
2013-08-05

Source: ClinicalTrials.gov record NCT01916642. Inclusion in this directory is not an endorsement.